CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Live-Cell Microscopy for quantitative analysis of CAR T Cell fratricide and immune synapse.
Live-Cell Microscopy for quantitative analysis of CAR T Cell fratricide and immune synapse.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR)T细胞疗法重新定义了癌症免疫治疗,在血液系统恶性肿瘤和实体瘤中均显示出显著疗效。然而,针对T细胞恶性肿瘤的CAR-T 细胞疗法受到同类相残的限制,即治疗性T细胞和内源性T细胞共同表达抗原所导致的自我定向细胞毒作用。该过程会损害CAR-T 细胞的扩增、存活和整体疗效。本研究提出一种基于活细胞显微成像的方法,用于观察和定量CAR-T 细胞同类相残及免疫突触。通过荧光标记、延时成像和自动化分析,我们追踪动态T细胞相互作用、细胞毒事件及突触结构。该方案可精确测量同类相残事件的动力学、连续杀伤行为和免疫突触形态,从而为优化CAR设计及阐明相关机制提供有价值的信息。这种基于成像的方法可补充传统检测,提供具有时间和空间分辨率的数据,进而加深我们对同类相残背景下CAR-T 细胞功能及细胞毒性调控的理解。
Chimeric antigen receptor (CAR) T cell therapy has redefined cancer immunotherapy, offering remarkable efficacy against hematologic malignancies and solid tumors.
However, CAR T cell therapy targeting T cell malignancies is limited by fratricide, self-directed cytotoxicity caused by shared antigen expression on both therapeutic and endogenous T cells. This process impairs CAR T cell expansion, viability, and overall efficacy. In this study, we present a live cell microscopy-based methodology to visualize and quantify CAR T cell fratricide and immune synapse. Through fluorescent labeling, time-lapse imaging and automated analysis, we track dynamic T cell interactions, cytotoxic events, and synaptic structures.
This protocol enables precise measurement of fratricide events kinetics, serial killing behavior, and immune synapse morphology, thereby offering valuable insights into CAR design optimization and underlying mechanisms. This imaging-based approach complements conventional assays by providing temporally and spatially resolved data, thereby enhancing our understanding of CAR T cell function and cytotoxic regulation in the context of fratricide.
MEMBER ACCOUNT
登录成功会直接打开下一页。